Metformin
-
Diabetes drug study explores cardiovascular risks for patients with kidney disease
An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease. Read MoreSep 25, 2019
-
VU study shows common diabetes drug can slow chronic kidney disease progression
Vanderbilt investigators have demonstrated in two studies that metformin-based treatments delay the onset and progression of chronic kidney disease (CKD) compared with other treatments for diabetes. Read MoreJun 26, 2014
-
Commonly prescribed oral diabetes drug offers cardiac benefits
Patients prescribed the diabetes drug metformin have a lower risk for heart attack, stroke and death than patients taking sulfonylurea drugs. Read MoreNov 8, 2012